Hsa_circ_0079929 in lung adenocarcinoma and its biological implications in lung adenocarcinoma progression

被引:0
|
作者
Shen, Yuan [1 ]
Han, Ruixue [2 ]
Yu, Xin [3 ]
Mao, Jing [4 ]
机构
[1] Huzhou Jiaotong Hosp, Dept Internal Med, Huzhou 313000, Peoples R China
[2] Yuhuan Second Peoples Hosp, Dept Oncol, Yuhuan 317605, Peoples R China
[3] Tradit Chinese Med Hosp Zhuji, Dept Resp Med, Zhuji 311800, Peoples R China
[4] Binhai Cty Peoples Hosp, Dept Resp & Crit Care Med, 299,Haibin Ave, Yancheng 224500, Peoples R China
关键词
Lung adenocarcinoma; Hsa_circ_0079929; Prognosis; Progression; CANCER EPIDEMIOLOGY; STATISTICS;
D O I
10.1186/s13019-024-03075-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundThis report investigated the expression, prognostic and biological implications of hsa_circ_0079929 in lung adenocarcinoma, which was based on clinical and experimental data.MethodsPatients with lung adenocarcinoma were screened and their clinical data and tissues (including cancerous tissues and adjacent normal tissues) were collected. The total RNA in tissues and cell lines was analyzed to obtained hsa_circ_0079929 level. The clinical significance was examined using the Chi-square test, Multi-variate Cox proportional hazards regression, and Kaplan-Meier curve. Cell malignant features were evaluated from three aspects (proliferation, migration, and invasion), detected by CCK-8 and Transwell methods.ResultsHsa_circ_0079929 raised in expression level in lung adenocarcinoma. This upregulation of hsa_circ_0079929 was correlated with adverse clinical parameters and poor outcome in terms of overall survival, resulting in an independent prognostic purpose molecular for overall survival. Overexpression of hsa_circ_0079929 could contribute to cell proliferation/migration/invasion, whereas its knockdown could inhibit these malignant features. Hsa_circ_0079929 was a molecular decoy for miR-1184 in lung adenocarcinoma cells.ConclusionsHsa_circ_0079929 could promote the malignant features of lung adenocarcinoma cells and may aid the follow up and therapeutic target discovery of lung adenocarcinoma.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Roles of CENPU in Lung Adenocarcinoma Progression and Invasion
    Lou, Y.
    Zhang, Y.
    Xu, J.
    Lu, J.
    Zhang, X.
    Zhang, W.
    Wang, H.
    Han, B.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S703 - S703
  • [42] Chromatin patterns associated with lung adenocarcinoma progression
    不详
    NUCLEUS-AUSTIN, 2013, 4 (04): : 259 - 259
  • [43] Amphiregulin Contributes to Tumor Progression in Lung Adenocarcinoma
    Xie, Mian
    Nukiwa, Toshihiro
    Nukiwa, Noriko
    Zhang, Li
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S419 - S419
  • [44] Amphiregulin contributes to tumor progression in lung adenocarcinoma
    Xie, M.
    Nukiwa, T.
    Nukiwa, N.
    Zhang, L.
    EJC SUPPLEMENTS, 2010, 8 (07): : 154 - 154
  • [45] RETRACTED: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma (Retracted Article)
    Wei, Shuang
    Zhang, Zun-yi
    Fu, Sheng-ling
    Xie, Jun-gang
    Liu, Xian-sheng
    Xu, Yong-jian
    Zhao, Jian-ping
    Xiong, Wei-ning
    CELL DEATH & DISEASE, 2016, 7 : e2388 - e2388
  • [46] Circ_100549 promotes tumor progression in lung adenocarcinoma through upregulation of BIRC6
    Chen, Feifei
    Chen, Juan
    Yuan, Yuan
    Fang, Surong
    Xie, Jing
    Xu, Xiaojuan
    Yang, Zhenhua
    Jiang, Jianzhong
    HISTOCHEMISTRY AND CELL BIOLOGY, 2024, 161 (06) : 493 - 506
  • [47] Hsa-miR-21 promoted the progression of lung adenocarcinoma by regulating LRIG1 expression
    Li Liu
    Xinhua Liu
    Chengpeng Gao
    Meijuan Liu
    Mengmeng Peng
    Leqiang Wang
    BMC Pulmonary Medicine, 25 (1)
  • [48] Clinical and Biological Characterization of Lung Enteric Adenocarcinoma
    Galli, G.
    Imbimbo, M.
    Busico, A.
    Perrone, F.
    Tamborini, E.
    Fabbri, A.
    Marano, G.
    Biganzoli, D.
    Ferrara, R.
    Lo Russo, G.
    Prelaj, A.
    Proto, C.
    Zilembo, N.
    De Toma, A.
    Pagani, F.
    Randon, G.
    Ganzinelli, M.
    Biganzoli, E.
    Pruneri, G.
    De Braud, F.
    Garassino, M.
    Signorelli, D.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S770 - S770
  • [49] In situ Quantification of Genomic Instability in Lung Adenocarcinoma: Biomarker Potential and the Biological Implications
    Kotecha, D.
    Moore, D. A.
    Le Quesne, J.
    JOURNAL OF PATHOLOGY, 2016, 240 : 30 - 30
  • [50] The oncogenetic role of stanniocalcin 1 in lung adenocarcinoma: a promising serum candidate biomarker for tracking lung adenocarcinoma progression
    Du, Yu-Zhen
    Gu, Xiao-Hua
    Cheng, Shao-Fei
    Li, Li
    Liu, Hua
    Hu, Liu-Ping
    Gao, Feng
    TUMOR BIOLOGY, 2016, 37 (04) : 5633 - 5644